Help shape GoConqr. What should we add next?

Flashcards

Clinical Trials Principles and Methods Flashcards

Justice Mundy Clinical Trials and Stratified Medicine English 46 cards

Cards in this deck (46)

  1. 1Clinical TrialAny form of planned experiment which involves human subjects.
    -Usually carried out on a sample from the population of patients with the disease.
    -Trials are needed so that new approaches are properly evaluated before they are widely adopted.
  2. 2CTIMPA Clinical Trial of an Investigational Medical Product.
  3. 3First Written Description of a Clinical Trial?The Bible: Daniel, Chapter 1:
    -King Nebuchadnezzar ordered his people to eat only meat and drink only wine.
    -Several objected, preferred to eat vegetables.
    -Allowed to eat legumes and drink water for 10 days.
    -‘Test us for 10 days…, then compare us with the young men who are eating the food of the royal court, and base your decision on how we look…’.
    -At the end of the 10 days, vegetarians appeared better nourished than the meat-eaters and were allowed to continue their diet.
  4. 4James Lind did what?James Lind FRSE (Scottish physician) did an early trial in which he studied citrus fruits to cure scurvy in 1747.
    -He studied 12 sailors that were similar to each other and divided them into 6 groups.
    -The groups were: Cider vs. sulfuric acid vs. vinegar vs. seawater vs. oranges/lemon vs. barley water.
    Only group 5 showed clear benefit, with some benefit in group 1.
  5. 5What did Karl Pearson (of the Pearson's Correlation) say about Sir Almroth Wright's anti-typhoid inoculation of the early twentieth century?'Assuming that the inoculation is not more than a temporary inconvenience it would seem possible to call for volunteers, but while keeping a register of all men who volunteered only to inoculate every second volunteer. In this way any spurious effect resulting from a correlation between immunity and caution would be got rid of.’
    -So he suggested you shouldn’t give the drug to everyone who volunteers. This is because people who volunteer are more motivated. So to take the people who volunteer and give the drug to half, and the other half should serve as the control.
  6. 6The Lanarkshire Milk ExperimentStudy done by 'Student" in a paper "The Lanarkshire Milk Experiment" published in 1931 in Biometrika, Vol. XXIII, pp. 398-406.
    -20,000 children, 67 schools in Lanarkshire.
    --10,000 children got no milk.
    --5,000 children got pasteurized milk.
    --5,000 children got raw milk.
    --outcomes were differences in before/after height and weight.
    -Assignments were done alphabetically or randomly, but teachers were allowed to adjust them (causing teachers to end up giving milk to more of the poorer children to help nourish them).
    -Children were weighed (in clothes) in February and again in June.
    -Control subjects turned out to be markedly healthier than milk subjects.
    -Children were weighted in their clothes so that the richer ones, who tended to be controls, lost more weight (clothes).
  7. 7Sir Bradford Hill's MRC trialsEnglish epidemiologist and statistician, pioneered the randomised clinical trial and, together with Richard Doll, was the first to demonstrate the connection between cigarette smoking and lung cancer.
  8. 81948 trial of streptomycin in tuberculosisStreptomycin in Tuberculosis Trials Committee (1948). “Streptomycin treatment of pulmonary tuberculosis. A medical Research Council investigation” Br Med J; 2 (4582): 769-82.
  9. 9Jonas Salk: Salk polio vaccine trial, 1954‘the most elaborate program of its kind in history, involving 20,000 physicians and public health officers, 64,000 school personnel, and 220,000 volunteers, with over 1,800,000 school children participating in the trial’
  10. 10Stages of CTIMPs1. Phase I: clinical pharmacology and toxicity.
    2. Phase II: initial clinical investigation for treatment.
    3. Phase III: full-scale evaluation of treatment.
    4. Medicinal product licensed.
    5. Phase IV: post-marketing surveillance.
  11. 11EthicsOxford dictionary meaning: “Moral principles, or a system of these”
    In context: “Moral principles that govern a person’s behaviour or the conducting of an activity.”
    OR
    “The branch of knowledge that deals with moral principles”
  12. 12Jenner and the smallpox vaccineEdward Jenner (1789)
    -Hypothesised that cowpox protected from people smallpox.
    -Inoculated his 8-year-old son with cowpox, then with smallpox, recorded subsequent health.
    -This lead to the development of the smallpox vaccine, and Jenner is widely regarded as having “saved more lives than the work of any other human.”
    Important consideration: INDIVIDUAL good vs. COLLECTIVE good.
  13. 13The Nuremberg Code 1947Created after 23 German doctors brought to trial in Nuremberg in 1945.
    As part of the verdict, these guidelines were put together regarding the treatment of human subjects in medical experiments.
  14. 14“Ethics and clinical research” Henry K. Beecher, New Engl J. Med. 274 (1966):1254-60.-Drew attention to 22 published medical studies presenting risk to subjects without their knowledge or approval, published in some of the most prestigious journals and conducted at some of the most prestigious institutions.
    -Paved the way for current guidelines on informed consent.
  15. 15Declaration of Helsinki-Ethical principles for Medical Research Involving Human Subjects.
    --Tokyo (1975), Venice (1983), Hong Kong (1989), 1996 (South Africa) etc.
    --US FDA have not recognised revisions after 1989, EU law refers to the 1996 revision only.
    “In medical research involving human subjects, the well-being of the individual research subject must take precedence over all other interests”.
  16. 16Placebo Controls are acceptable when...-No standard therapy available.
    -Standard therapy no better than placebo.
    -Standard treatment is placebo.
    -Doubt regarding the net therapeutic advantage of standard therapy.
    -Standard treatment is unavailable (cost, supply).
  17. 17True consent is...-Informed
    -Given by someone who has capacity.
    -Voluntary
  18. 18Required Elements of patient information document and consent form-Required Element 1- The Research Declaration
    -Required Element 2- The foreseeable risks or discomforts
    -Required Element 3- The potential benefits
    -Required element 4- Alternatives to participation
    -Required Element 5- Confidentiality
    -Required Element 6- Compensation
    -Required Element 7- Contact Information
    Required Element 8- Participation is Voluntary
  19. 19The Elixir Tragedy, 1937-Sulfanilamide had dramatic curative properties against streptococcal infections.
    -Safely used in tablet and powder form.
    -Rising demand for liquid.
    -Chief chemist found that sulfanilamide dissolved in diethylene glycol.
    -Tested for taste, appearance and fragrance – all satisfactory.
    -Shipped across USA.
    -Result- mass poisoning, 105 known deaths.
    -Diethylene glycol, anti-freeze, is toxic.
    -Huge recovery operation launched, “nationwide race against death”.
    -Not illegal! There were no requirements to test new drugs.
  20. 20Thalidomide, 1960s-Investigated as treatment for respiratory infections, marketed as Grippex following clinical trials.
    -Wonder drug- completely safe, even in overdose – prescribed for all sorts of conditions.
    -Researchers discovered anti-emetic properties. Marketed as Contergan for morning sickness.
    -Licensed worldwide. Licensed in the UK in 1958.
    -16th December 1961, Dr. William McBride writes to Lancet.
    --“…In recent month I have observed that the incidence of multiple severe abnormalities in babies delivered of women who were given the drug thalidomide…bony development seems to be affected…have any of your readers seen similar abnormalities who have taken this drug during pregnancy?”
    -Drug ‘pulled’ that year.
    -Affected over 10,000 babies worldwide.
    -Resulted in the regulation of drug development.
    -The Medicine and Healthcare Products Regulatory Agency (MHRA) in the UK was set up (over time) as a direct result of this tragedy.
  21. 21Thalidomide??-Currently used to treat multiple myeloma.
    -Very strict conditions of use – patients must not become pregnant.
    -No problems in the UK.
    -Elsewhere, however…
    --In places such as third world countries where they do not have the same regulations as the UK, they are still experiencing such problems with thalidomide.
  22. 22Aims of the MHRA-To protect public health through regulation, including the development of benefit and risk profiles for medicines and devices.
    -To promote public health by helping people to understand the risks and benefits of the products they use.
    -To improve public health by facilitating the development of products that will benefit people.
  23. 23Regulatory bodies-UK
    --Medicines and Healthcare products Regulatory Agency (MHRA).
    --http://www.mhra.gov.uk
    -Europe
    --European Medicines Agency (EMA)
    -USA
    --Food and Drug Administration (FDA)
  24. 24TGN1412-London, 2006
    -First-in-man clinical trial of TGN1412.
    -Six patients given treatment at a dose 500 times smaller than was deemed safe in pre-clinical studies.
    -Within minutes, all experienced life-threatening reactions.
    -Drug ‘pulled’, investigation launched by MHRA.
  25. 25ICHThe International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
    -Developed following Nuremberg Code and Declaration of Helsinki.
    -Internationally recognised – covers all European member states, North America, Japan, Australia.
    -Ethical and scientific quality requirements.
    -Covers the design, conduct, recording and reporting of clinical trials that involve the participation of human subjects.
    -Basis of MHRA inspections and EU legislation.
  26. 26Why have GCP?-Compliance with GCP:
    --Provides public assurance that the rights, safety and wellbeing of participants are protected and consistent with the Declaration of Helsinki.
    --Ensures that clinical trial data and reported results are accurate and credible.
  27. 27CTIMP Sponsor-Responsible for everything done in the trial.
    -“An individual, company, institution or organisation which takes responsibility for the initiation, management and/or financing of a clinical trial.”
    -Before a CTIMP starts, all trial-related duties and functions should be defined, established and allocated by the sponsor.
    -The NHS has produced a Sponsorship Principles document to clarify the role of the sponsor in a trial.
    -Glasgow CTU sponsor is usually NHS GG&C, sometimes in conjunction with the University of Glasgow.
  28. 28Research Ethics Committee-Protects the rights and interests of the people who will be in the trial.
    -Often based at local hospitals.
    -Formed of local people, such as health professionals, patients, lawyers and members of the public. MUST include members who are not health professionals.
    -Part of NHS Research Authority.
  29. 29The research ethics committee decides whether...-The potential benefits of a new treatment are likely to outweigh the side effects;
    -The information provided to help people decide whether they want to take part in a trial is clear and satisfactory;
    -The way people will be asked to take part in a trial is appropriate;
    -There will be compensation for people in the trial if something goes wrong;
    -Travel expenses should be offered to people who take part in the trial.
  30. 30Integrated Research Application System (IRAS)-A single system for applying for the permissions and approvals for health and social care / community care research in the UK.
    -Enables you to enter the information about your project once instead of duplicating information in separate application forms.
    -Uses filters to determine what approvals are needed, what information is required and what declarations need to be signed.
  31. 31EndpointsA clinical trial endpoint is defined as a measure that allows us to decide whether the null hypothesis of a clinical trial should be rejected or accepted.
  32. 32EquivalenceDemonstration that the absolute reduction of events achieved by one treatment is similar to that achieved by another treatment (within a pre-defined range).
  33. 33Clinical equivalenceTherapeutic equivalence based on clinical outcomes such as reduced rate of death or stroke.
  34. 34The case Report Form (CRF)Form used to collect patient data.
    Paper or electronic (eCRF) – each has its own challenges.
    Central to the trial – can affect the success of the trial.
    The CRF should be fully designed and finalised BEFORE the first patient is enrolled.
    Ideally, a CRF will be designed in conjunction with the protocol, by a team including clinicians, site-monitors, programmers, data management and statisticians.
    Drafts should be tested with investigators and study nurses during the development stage
  35. 35Adverse Events (Pharmacovigilance)An adverse event (AE) is defined in the Medicines for Human Use (Clinical Trials) Regulations (2004) as:
    “any untoward medical occurrence in a subject to whom a medicinal product has been administered, including occurrences which are not necessarily caused by or related to that product”.
  36. 36Adverse ReactionAny untoward and unintended response in a subject to an investigational medicinal product which is related* to any dose administered to that subject.
    *as deemed by the study investigator or sponsor to have a “reasonable causal relationship”.
  37. 37Serious Adverse EventA serious adverse event (SAE) is any adverse event which:
    -Results in death.
    -Is life-threatening*
    -Requires hospitalisation or prolonged or existing hospitalisation.
    -Results in persistent or significant disability or incapacity.
    -Consists of a congenital anomaly or birth defect.
    -Or anything the investigator deems to be of Clinical significance.
  38. 38Quantitative / Numeric-Continuous:
    --Usually measurement data.
    --A one unit change means the same, anywhere on the scale.
    --Examples: height, blood pressure serum albumin.
    -Discrete:
    --Values are distinct and separate.
    --Example: Number of children per household
  39. 39Qualitative / Categorical-Ordinal:
    --Categories have a natural order.
    --Example: disease mild, moderate, severe.
    -Nominal:
    --Categories have no natural order.
    --Example: black, caucasian, Asian.
  40. 40Sample Size CalculationWhy do we need a sample size calculation?
    -Should be part of the study protocol (see ICH/GCP 6.9.2).
    -Implications for funding.
    -Ethical issues
    -Implications for publications.
    The sample should be:
    -Representative of the population of interest.
    -Large enough to be confident in the results of the analysis.
  41. 41Types of censoringRight Censoring (General Situation in trials)
    -Leukaemia patient who has not had a recurrence within the 24 week follow-up period.
    Left Censoring
    -Onset of a pre-symptomatic illness such as cancer. We know that the event occurred before the symptoms began – but we can’t say when.
    Interval Censoring
    -Infection with a disease such as HIV/AIDS with regular testing (e.g. annually).
    ---We know at some point in a year, just not exactly when, for example.
  42. 42ConfoundingA third variable that distorts the observed relationship between the treatment and outcome.
  43. 43Trial Master FileTrial Master File (TMF or eTMF) should contain ALL essential documents relating to a clinical trial.
    ICH Section 8 lists requirements for a clinical trial master file.
    ICH guidelines list documents that should be in the TMF before trial commences, during the trial, and after the trial has been completed.
    Trials should have a Sponsor Trial Master File and an Investigator Trial Master File. Individual sites should have a file with documentation relevant to those sites.
  44. 44Delegation Log (IMPORTANT)The Clinical Trial Delegation Log is a vital part of clinical trial documentation.
    At the start of the trial, the investigator must assign significant trial duties to suitably qualified individuals. This must be agreed by both the investigator and the individuals.
    These duties must be listed in the delegation log. All staff listed on the delegation log must have a current Good Clinical Practice certificate.
    Sponsors often have delegation log templates. These is also a template on the Clinical Trials Toolkit website.
  45. 45IDMCIndependent Data Monitoring Committee
    -Group of experts independent of the trial sponsor.
    Should include:
    --At least one statistician.
    --Clinicians in the field of study (ie condition being treated).
    --Clinicians in the field of potential adverse events.
    -Reviews safety data (adverse events) at various stages of the trial.
    -Provides guidance to the sponsor that the trial continues as it is, is modified, or is stopped.
    -Guidance is usually concerned with safety.
    -IDMC can recommend a trial be stopped if there is overwhelming evidence of clear benefit to the treatment arm.
  46. 46TSCTrial Steering Committee
    -Independent committee of experts led by an independent chair.
    -Provides overall supervision of the trial, from the beginning.
    -Ensures that the trial is being conducted in accordance with the principles of Good Clinical Practice and the relevant regulations.
    -Provides expert advice to the investigators on all aspects of the trial.
    -Ultimate decision on the continuation or termination of the trial rests with the TSC.

Information

Description
Clinical Trials and Stratified Medicine Flashcards on Clinical Trials Principles and Methods Flashcards, created by Justice Mundy on 10/04/2017.
Created by
Justice Mundy
Views
3
Rating

More on Clinical Trial Design and Phases

Feedback

What is it about?

What should we add next?